Welcome to BioMarket Group!

Biologicals

In this section you will find Therapeutics Line of Treatment Biologicals market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.

8 Item(s)

per page

Set Ascending Direction
  1. Biologicals in Oncology Drug Pipeline Update

    $3,675.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 1371 companies plus partners who are today developing 2823 biological drugs in 6088 developmental projects in cancer across 801 different targets. In addition, there are 25 suspended drugs and another 1050 drugs where development has been ceased. Learn More

  2. Nucleic Acid Therapies in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 308 companies plus partners who are today developing 381 nucleic acid therapy drugs in 775 developmental projects in cancer across 251 different targets. In addition, there are 9 suspended drugs and another 211 drugs where development has been ceased. Learn More

  3. Peptides in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 340 companies plus partners who are today developing 356 peptide drugs in 778 developmental projects in cancer across 252 different targets. In addition, there are 4 suspended drugs and another 148 drugs where development has been ceased. Learn More

  4. Proteins in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 455 companies plus partners who are today developing 521 protein drugs in 914 developmental projects in cancer across 229 different targets. In addition, there are 2 suspended drugs and another 207 drugs where development has been ceased. Learn More

  5. Cellular Therapy in Oncology Drug Pipeline Update

    $1,495.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 164 companies plus partners who are today developing 272 cellular therapy drugs in 577 developmental projects in cancer across 92 different targets. In addition, there are 7 suspended drugs and another 66 drugs where development has been ceased. Learn More

  6. Analytical Tool - Antibodies in Oncology

    $3,750.00
    Published by BioSeeker Group on Jan 12th, 2015
    Premium analysis tool on the commercial development of antibodies in oncology. This unique tool integrates system biology into traditional business information in order to achieve best practice when it comes to analyzing and understand targeted therapy and personalized medicine of antibodies in oncology. Learn More

  7. Analytical Tool - Antibodies and Peptides in Oncology

    $8,925.00
    Published by BioSeeker Group on Mar 25th, 2014
    A unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody and peptide cancer R&D and business development. Learn More

  8. Analytical Tool - Peptides in Oncology

    $4,650.00
    Published by BioSeeker Group on Mar 25th, 2014
    A unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer peptide R&D and business development. Learn More

8 Item(s)

per page

Set Ascending Direction

Biologicals

In this section you will find Therapeutics Line of Treatment Biologicals market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.

8 Item(s)

per page

Set Ascending Direction
  1. Biologicals in Oncology Drug Pipeline Update

    $3,675.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 1371 companies plus partners who are today developing 2823 biological drugs in 6088 developmental projects in cancer across 801 different targets. In addition, there are 25 suspended drugs and another 1050 drugs where development has been ceased. Learn More

  2. Nucleic Acid Therapies in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 308 companies plus partners who are today developing 381 nucleic acid therapy drugs in 775 developmental projects in cancer across 251 different targets. In addition, there are 9 suspended drugs and another 211 drugs where development has been ceased. Learn More

  3. Peptides in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 340 companies plus partners who are today developing 356 peptide drugs in 778 developmental projects in cancer across 252 different targets. In addition, there are 4 suspended drugs and another 148 drugs where development has been ceased. Learn More

  4. Proteins in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 455 companies plus partners who are today developing 521 protein drugs in 914 developmental projects in cancer across 229 different targets. In addition, there are 2 suspended drugs and another 207 drugs where development has been ceased. Learn More

  5. Cellular Therapy in Oncology Drug Pipeline Update

    $1,495.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 164 companies plus partners who are today developing 272 cellular therapy drugs in 577 developmental projects in cancer across 92 different targets. In addition, there are 7 suspended drugs and another 66 drugs where development has been ceased. Learn More

  6. Analytical Tool - Antibodies in Oncology

    $3,750.00
    Published by BioSeeker Group on Jan 12th, 2015
    Premium analysis tool on the commercial development of antibodies in oncology. This unique tool integrates system biology into traditional business information in order to achieve best practice when it comes to analyzing and understand targeted therapy and personalized medicine of antibodies in oncology. Learn More

  7. Analytical Tool - Antibodies and Peptides in Oncology

    $8,925.00
    Published by BioSeeker Group on Mar 25th, 2014
    A unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody and peptide cancer R&D and business development. Learn More

  8. Analytical Tool - Peptides in Oncology

    $4,650.00
    Published by BioSeeker Group on Mar 25th, 2014
    A unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer peptide R&D and business development. Learn More

8 Item(s)

per page

Set Ascending Direction